S.No | Ailment | Route | Dose Min | Dose Max | Unit | Dosage Form | Frequency | Additional Info |
---|---|---|---|---|---|---|---|---|
1 | Locally advanced prostatic cancer at high risk for disease progression | Oral | 150 | mg | Tablet | o.d. | may be given as monotherapy or adjuvant therapy to surgery or radiotherapy | |
2 | Palliative treatment of advanced prostatic cancer | Oral | 50 | mg | Tablet | o.d. |
S.No | Ailment | Age Min | Age Max | Weight ( Kg ) | Route | Dose Min | Dose Max | Unit | Dosage Form | Frequency | Additional Info |
---|
Pathway of DIETARY Product
DIETARY Substance Interactions
ContraIndication DIETARY Substance